PDE5i Use After Robotic Prostate Cancer Surgery Linked to Better Survival
Phosphodiesterase-5 inhibitor use after robot-assisted radical prostatectomy is associated with a lower risk of death, a study suggests.
Stay updated with breaking news from Erectile Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phosphodiesterase-5 inhibitor use after robot-assisted radical prostatectomy is associated with a lower risk of death, a study suggests.
Phosphodiesterase-5 inhibitor use after robot-assisted radical prostatectomy improves survival, a propensity score matched analysis showed.
Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more
Researchers explored the manifestation of erectile dysfunction after COVID-19 recovery.
Whole gland cryoablation for localized prostate cancer resulted in high rates of biochemical recurrence-free survival and excellent functional outcomes.